Jimin Zhang

Jimin Zhang is an accomplished professional in the field of translational medicine, currently serving as the Associate Director of Translational Medicine at Duality Biologics since June 2025, leading initiatives in oncology and autoimmune disease. Prior to this role, Jimin held the position of Translational Medicine Lead and Principal Scientist at Genmab from 2021 to 2025, where responsibilities included overseeing biomarker strategies for the immuno-oncology program epcoritamab. From 2015 to 2021, Jimin was an Associate Principal Scientist at Insmed Incorporated, leading research on the INS1007 project targeting inflammatory and autoimmune diseases and participating in cross-functional development teams. Earlier research experience includes a Postdoctoral Fellowship and Graduate Fellowships at The Child Health Institute of New Jersey and Robert Wood Johnson Medical School, focusing on inflammatory disease models and T cell biology. Jimin holds a PhD in Immunology from Rutgers University and a BS in Biochemistry from Sun Yat-sen University.